RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2018; 29(12): 1617-1621
DOI: 10.1055/s-0037-1610178
DOI: 10.1055/s-0037-1610178
letter
Biomimetic Total Synthesis of Scabellone B
The project is supported by the National Natural Science Foundation of China (21772153, 21642006), the Key Science and Technology Innovation Team of Shaanxi Province (2017KCT-37), and the China Postdoctoral Science Foundation (334100041).
Weitere Informationen
Publikationsverlauf
Received: 03. März 2018
Accepted after revision: 15. Mai 2018
Publikationsdatum:
18. Juni 2018 (online)
Abstract
A biomimetic total synthesis of scabellone B is described. Through sequential regioselective introduction of a geranyl group by means of silyl protection, oxidative dimerization, and biomimetic oxo-6π electrocyclization with good cyclization selectivity, a biomimetic approach to scabellone B was achieved in five steps and 32% overall yield.
Key words
total synthesis - protecting groups - dimerization - electrocyclic reactions - natural productsSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0037-1610178.
- Supporting Information
- NMR
-
References and Notes
- 1 Chan ST. S. Pearce AN. Januario AH. Page MJ. Kaiser M. McLaughlin RJ. Harper JL. Webb VL. Barker D. Copp BR. J. Org. Chem. 2011; 76: 9151
- 2a Pearce AN. Chia EW. Berridge MV. Clark GR. Harper JL. Larsen L. Maas EW. Page MJ. Perry NB. Webb VL. Copp BR. J. Nat. Prod. 2007; 70: 936
- 2b Pearce AN. Chia EW. Berridge MV. Maas EW. Page MJ. Harper JL. Webb VL. Copp BR. Tetrahedron 2008; 64: 5748
- 2c Appleton DR. Chuen CS. Berridge MV. Webb VL. Copp BR. J. Org. Chem. 2009; 74: 9195
- 2d Liew LP. P. Kaiser M. Copp BR. Bioorg. Med. Chem. Lett. 2013; 23: 452
- 2e Liew LP. P. Pearce AN. Kaiser M. Copp BR. Eur. J. Med. Chem. 2013; 69: 22
- 2f Harper J. Khalil I. Shaw L. Bourguet-Kondracki M.-L. Dubois J. Valentin A. Barker D. Copp BR. Mar. Drugs 2015; 13: 5102
- 2g Cadelis M. Bourguet-Kondracki M.-L. Dubois J. Valentin A. Barker D. Copp BR. Bioorg. Med. Chem. 2016; 24: 3102
- 2h Cadelis MM. Bourguet-Kondracki M.-L. Dubois J. Kaiser M. Brunel JM. Barker D. Copp BR. Bioorg. Med. Chem. 2017; 25: 4433
- 3a Chan ST. S. Pullar MA. Khalil IM. Allouche E. Barker D. Copp BR. Tetrahedron Lett. 2015; 56: 1486
- 3b Lim DS. W. Anderson EA. Synthesis 2012; 44: 983
- 4 Yang X. Gulder TA. M. Reichert M. Tang C. Ke C. Ye Y. Bringmann G. Tetrahedron 2007; 63: 4688
- 5a Joseph-Nathan P. Hernández JD. Román LU. García EG. Mendoza V. Mendoza S. Phytochemistry 1982; 21: 1129
- 5b Georgantea P. Ioannou E. Vagias C. Roussis V. Tetrahedron Lett. 2013; 54: 6920
- 6 Carney JR. Scheuer PJ. Tetrahedron Lett. 1993; 34: 3727
- 7a Anderson JC. Denton RM. Wilson C. Org. Lett. 2005; 7: 123
- 7b Smith MJ. Nawrat CC. Moody CJ. Org. Lett. 2011; 13: 3396
- 7c Gao S. Hu X. Org. Chem. Front. 2017; 4: 1493
- 8a Li X. Yang J. Kozlowski MC. Org. Lett. 2001; 3: 1137
- 8b Takeya T. Kondo H. Otsuka T. Tomita K. Okamoto I. Tamura O. Org. Lett. 2007; 9: 2807
- 8c Love BE. Bonner-Stewart J. Forrest LA. Synlett 2009; 813
- 8d Love BE. Bonner-Stewart J. Forrest LA. Tetrahedron 2009; 50: 5050
- 8e Neelamegam R. Palatnik MT. Fraser-Rini J. Slifstein M. Abi-Dargham A. Easwaramoorthy B. Tetrahedron Lett. 2010; 51: 2497
- 8f Love BE. Duffy BC. Simmons AL. Tetrahedron 2014; 55: 1994
- 8g Romaine IM. Sulikowski GA. Tetrahedron 2015; 56: 3617
- 8h Krylov IB. Paveliev SA. Shelimov BN. Lokshin BV. Garbuzova IA. Tafeenko VA. Chernyshev VV. Budnikov AS. Nikishin GI. Terent’ev AO. Org. Chem. Front. 2017; 4: 1947
- 9a Linn BO. Shunk CH. Wong EL. Folkers K. J. Am. Chem. Soc. 1963; 85: 239
- 9b Schudel P. Mayer H. Metzger J. Rüegg R. Isler O. Helv. Chim. Acta 1963; 46: 2517
- 9c Inoue K. Shiobara Y. Nayeshiro H. Inouye H. Wilson G. Zenk MH. Phytochemistry 1984; 23: 307
- 9d Khanna RN. Sharma PK. Thomson RH. J. Chem. Soc., Perkin Trans. 1 1987; 1821
- 9e Ishibashi M. Ohizumi Y. Cheng JF. Nakamura H. Hirata Y. Sasaki T. Kobayashi J. J. Org. Chem. 1988; 53: 2855
- 9f Mukai K. Okabe K. Hosose H. J. Org. Chem. 1989; 54: 557
- 9g Nicolaou KC. Sasmal PK. Xu H. J. Am. Chem. Soc. 2004; 126: 5493
- 9h Lee YR. Choi JH. Yoon SH. Tetrahedron Lett. 2005; 46: 7539
- 9i Lumb J.-P. Trauner D. Org. Lett. 2005; 7: 5865
- 9j Habonimana P. Claessens S. De Kimpe N. Synlett 2006; 2472
- 9k Carbone A. Lucas CL. Moody CJ. J. Org. Chem. 2012; 77: 9179
- 9l Zeng H. Duan D. Tang B. Synlett 2015; 26: 927
- 10 Scabellone BEt3N (47 mg, 0.54 mmol) was added to solution of biquinone 6 (100 mg, 0.18 mmol) in CH2Cl2 (5 mL), and the mixture was stirred for 5 min. The mixture was then concentrated by vacuum and purified by column chromatography (silica gel) to give a purple oil; yield: 95 mg (95%); Rf = 0.3 (EtOAc–PE, 1:5). IR (CCl4): 3467, 2922, 1684, 1594, 1221, 750 cm–1. 1H NMR (400 MHz, CDCl3): δ = 6.40 (s, 1 H), 6.00 (d, J = 8 Hz, 1 H), 5.79 (s, 1 H), 5.50 (s, 1 H), 5.27 (d, J = 8 Hz, 1 H), 5.05 (m, 1 H), 5.00 (t, J = 4 Hz, 1 H), 4.93 (t, J = 4 Hz, 1 H), 3.88 (s, 3 H), 3.79 (s, 3 H), 3.57 (m, 1 H), 3.36 (dd, J = 12 Hz, 1 H), 1.94–1.98 (m, 4 H), 1.92–1.94 (m, 2 H), 1.92 (s, 3 H), 1.85–1.87 (m, 2 H), 1.62 (s, 3 H), 1.59 (s, 3 H), 1.56 (s, 3 H), 1.50 (s, 3 H), 1.49 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 182.7, 178.9, 158.0, 151.5, 150.2, 144.5, 139.3, 137.7, 137.2, 131.9, 131.8, 130.9, 127.0, 124.4, 124.0, 123.7, 117.0, 111.2, 107.4, 98.5, 67.8, 56.3, 56.2, 40.0, 39.9, 26.7, 26.5, 26.3, 25.7, 25.7, 17.7, 17.6, 17.4, 16.7. HRMS (ESI+): m/z [M + H]+ calcd for C34H43O6, 547.3054; found: 547.3041.